Видео ютуба по тегу Neil Iyengar

Neil Iyengar: Diet and Cancer Prevention
Neil Iyengar: Diet and Cancer Prevention
Speaking of Science:
Speaking of Science: "Optimizing Lifestyle to Improve Cancer Outcomes" w/ Neil Iyengar, MD
SABCS 2021: Lifestyle: Exercise and diet
SABCS 2021: Lifestyle: Exercise and diet
DESTINY-Breast11, DESTINY-Breast05 & What Comes Next - Dr. Neil Iyengar & Dr. Komal Jhaveri
DESTINY-Breast11, DESTINY-Breast05 & What Comes Next - Dr. Neil Iyengar & Dr. Komal Jhaveri
From GLP-1s to METAP2: Dr. Neil Iyengar on the Future of Metabo-Oncology and Long-Term Patient Care
From GLP-1s to METAP2: Dr. Neil Iyengar on the Future of Metabo-Oncology and Long-Term Patient Care
Dr. Mark Pegram and Dr. Neil Iyengar - T-DXd’s Rise in HER2+ & HER2-Low Breast Cancer
Dr. Mark Pegram and Dr. Neil Iyengar - T-DXd’s Rise in HER2+ & HER2-Low Breast Cancer
Breast cancer survivors can benefit from weight management and nutrition interventions
Breast cancer survivors can benefit from weight management and nutrition interventions
#infiniteStrenghtMBCC24 - Kate Pfitzer with Dr. Neil Iyengar
#infiniteStrenghtMBCC24 - Kate Pfitzer with Dr. Neil Iyengar
Plenary 4: What can we tell our patients
Plenary 4: What can we tell our patients
How Metabolic Health Impacts Cancer Risk, Progression, and Therapy Response
How Metabolic Health Impacts Cancer Risk, Progression, and Therapy Response
Incretin mimetics in reducing breast cancer risk
Incretin mimetics in reducing breast cancer risk
Clinical Trial Updates, and Breast Cancer Outcomes in Black Women: 2023 Best of Breast Conference
Clinical Trial Updates, and Breast Cancer Outcomes in Black Women: 2023 Best of Breast Conference
Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Enhancing Efficacy and Safety in HR+/HER2- Breast Cancer with Novel PI3Kα Inhibitors
Dr. Neil Iyengar & Dr. Mark Robson - PARP Inhibitors in Early Breast Cancer: Who and When to Treat
Dr. Neil Iyengar & Dr. Mark Robson - PARP Inhibitors in Early Breast Cancer: Who and When to Treat
Well Care and Decreasing Cancer Risk: Obesity, Inflammation, Insulin Resistance, Diet and Exercise
Well Care and Decreasing Cancer Risk: Obesity, Inflammation, Insulin Resistance, Diet and Exercise
Role of GLP-1 agonists in breast cancer survivorship setting
Role of GLP-1 agonists in breast cancer survivorship setting
SABCS 2024: Survivorship - biomarker predictors and other survival associated factors
SABCS 2024: Survivorship - biomarker predictors and other survival associated factors
[STO Spotlight] Unedited Neil Iyengar on exercise as first-line therapy for HR + breast cancer
[STO Spotlight] Unedited Neil Iyengar on exercise as first-line therapy for HR + breast cancer
Shaping the Future of Breast Oncology and Survivorship at Emory's Winship Cancer Institute
Shaping the Future of Breast Oncology and Survivorship at Emory's Winship Cancer Institute
Plenary 2: Lifestyle impacts on immunotherapy
Plenary 2: Lifestyle impacts on immunotherapy
Breast Site Group Presentation: HER2-Low & HER2-UltraLow Metastatic Cancer - November 20, 2025
Breast Site Group Presentation: HER2-Low & HER2-UltraLow Metastatic Cancer - November 20, 2025